Methods for the treatment of infections and tumors

Details for Australian Patent Application No. 2009319701 (hide)

Owner Dana-Farber Cancer Institute, Inc. Emory University

Inventors Ahmed, Rafi; Amara, Rama; Velu, Vijayakumar; Titanji, Kehmia; Freeman, Gordon

Agent Fisher Adams Kelly

Pub. Number AU-A-2009319701

PCT Pub. Number WO2010/063011

Priority 61/118,570 28.11.08 US

Filing date 27 November 2009

Wipo publication date 3 June 2010

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/0781 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - B cells

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/063011 Priority application(s): WO2010/063011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319719-Comminution and densification of biomass particles

2009319698-Head and neck radiation localization using oral appliance